Table 2. Measurement of SAA, ApoC-II, CRP and CA19.9 by ELISA in validation set.
|
SAA (ng ml−1) |
ApoC-II (μg ml−1) |
CRP (ng ml−1) |
CA19.9 U l
−1
|
||||||
|---|---|---|---|---|---|---|---|---|---|
| N | Mean | s.d. | Mean | s.d. | Mean | s.d. | Mean | s.d. | |
| PDCA | 57 | 104.0 | 3.9 | 6.2 | 2.5 | 3.7 | 4.1 | 105 | 4.1 |
| APCA | 13 | 32.9 | 3.8 | 15.3 | 3.7 | 3.4 | 4.3 | 267 | 2.1 |
| HV | 12 | 9.9 | 2.0 | 13.7 | 1.6 | 2.4 | 4.9 | — | — |
| P by ANOVA | 0.000 | 0.001 | n.s. | n.s. | |||||
| P for PDC vs APCA | 0.013 | 0.007 | |||||||
| P for PDC vs HV | 0.000 | 0.027 | |||||||
Abbreviations: ANOVA=analysis of variance; APCA=advanced pancreatic carcinoma; HV=healthy volunteers; PDCA=pancreatic ductal adenocarcinoma. Values are geometric means±s.d.